Unclaimed brand
Ncardia provides human iPSC CRO services and cell models for drug discovery, safety pharmacology and disease modelling.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#FF1E1F
Torch Red
255, 30, 31
360, 100, 56
0, 88, 88, 0
#4D96D5
Havelock Blue
77, 150, 213
208, 62, 57
64, 30, 0, 16
#561426
Heath
86, 20, 38
344, 62, 21
0, 77, 56, 66
Ncardia is a biotechnology partner specializing in human induced pluripotent stem cell (iPSC) products and contract research services. The company supports drug discovery and the development of drug, gene and cell therapies with physiologically relevant human cell models, scalable assays and expertise in iPSC technology. Its product portfolio includes cardiovascular models such as ventricular and atrial cardiomyocytes, endothelial cells and heart tissue, as well as neural models including astrocytes, microglia, GABAergic neurons and excitatory neurons. Ncardia also offers smooth muscle cells and specialized products such as plate-ready cardiomyocytes.
Its services include iPSC reprogramming, gene editing, cell differentiation, iPSC-based assays and custom screening applications. These capabilities support disease modelling, drug discovery, regenerative medicine, toxicology and safety pharmacology. Ncardia’s ready-to-use assays and custom platforms are designed to help researchers assess candidate therapies and make more informed development decisions. Its IO Safety Panel combines cardiac and other tissue safety readouts to evaluate functional toxicity in immuno-oncology research.
Company type
Privately Held
Year founded
2011
Company size
51-200 employees
The Ncardia name, logos and brand assets are trademarks of Ncardia and its affiliates. Brandfetch isn't affiliated with or endorsed by Ncardia. Their use is subject to Ncardia's brand guidelines.
